BRAND_ANALYSIS #ASTRAZENECA HEALTH & PHARMA #9 OF 26 IN HEALTH & PHARMA INTERESTING

AstraZeneca

· Public · Updated 09 Jul 2026 08:27 UTC
#130 of 1208 overall by tension · #9 of 26 in Health & Pharma
22 Interesting
The Silent Giant
Analysis

AstraZeneca inverts the pattern: strong business (B=80) and structural cultural weight (C=58) crushed by -0.20 sentiment, likely tied to vaccine skepticism and pharma distrust. Financial performance cannot outrun reputational gravity.

IN THE NEWS (100 articles this week)
AstraZeneca stock dives 9% after heart drug trial misses target - CNBC
AstraZeneca secures ex-China license for Sino Biopharmaceutical's experimental COPD drug - Reuters
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership - WSJ
Cultural Score
58 / 100
Business Score
80 / 100
TENSION▁▁▁▁▂▂▂▁▂▂▂▂▂▂
CULTURAL▅▅▅▅▄▄▄▄▄▅▅▅▅▅
BUSINESS▆▆▆▆▆▆▆▅▆▆▆▆▆▆
Loading...
Wikipedia Momentum 22/40
News Presence 36/35
Search InterestRedistributed to other dimensions
Stock Momentum 20/30
Market Position 22/25
Revenue Growth 22/25
Earnings Health 16/20
Avg Daily (7d)422
Avg Daily (90d)520
7d/90d Ratio0.81x
Price$189.28
30d Change+1.8%
Market Cap$293.5B
Profit Margin17.2%
AstraZeneca's tension is 22. Commerce outpacing culture. sociologyofcapitalism.com/brand/astrazeneca
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/astrazeneca.html" width="320" height="200" frameborder="0"></iframe>